aspirin_TS_487964117 A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk. Use of low-dose aspirin after a diagnosis of prostate ...
Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback